Descriptor English: | Paliperidone Palmitate | ||||
Descriptor Spanish: |
Palmitato de Paliperidona
| ||||
Descriptor Portuguese: | Palmitato de Paliperidona | ||||
Descriptor French: | Palmitate de palipéridone | ||||
Entry term(s): |
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one 9 Hydroxy risperidone 9 Hydroxyrisperidone 9 OH risperidone 9-Hydroxy-risperidone 9-Hydroxyrisperidone 9-OH-risperidone Invega Invega Sustenna Paliperidone Palmitate, Paliperidone R 76477 R-76477 R76477 Sustenna, Invega |
||||
Tree number(s): |
D03.383.129.385.650 D03.383.742.592 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068882 | ||||
Scope note: | A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antipsychotic Agents Serotonin 5-HT2 Receptor Antagonists Dopamine D2 Receptor Antagonists |
||||
Registry Number: | R8P8USM8FR | ||||
Public MeSH Note: | 2016; PALIPERIDONE was indexed under PYRIMIDINES and ISOXAZOLES, 1993-2015; PALIPERIDONE PALMITATE was indexed under ISOXAZOLES and PALMITATE 2010-2015. |
||||
History Note: | 2016 (1993) |
||||
DeCS ID: | 55917 | ||||
Unique ID: | D000068882 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/06 | ||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Paliperidone Palmitate
- Preferred
Paliperidone
- Narrower
Invega
- Narrower
Invega Sustenna
- Narrower
R 76477
- Narrower
Concept UI |
M0546009 |
Scope note | A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA. |
Preferred term | Paliperidone Palmitate |
Entry term(s) |
Palmitate, Paliperidone |
Concept UI |
M0211957 |
Preferred term | Paliperidone |
Entry term(s) |
3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one 9 Hydroxy risperidone 9 Hydroxyrisperidone 9 OH risperidone 9-Hydroxy-risperidone 9-Hydroxyrisperidone 9-OH-risperidone |
Concept UI |
M0505003 |
Preferred term | Invega |
Concept UI |
M000604030 |
Preferred term | Invega Sustenna |
Entry term(s) |
Sustenna, Invega |
Concept UI |
M0211960 |
Preferred term | R 76477 |
Entry term(s) |
R-76477 R76477 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey